SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001516551-24-000083
Filing Date
2024-09-04
Accepted
2024-09-04 17:25:07
Documents
2
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1725483415.html 3  
1 FORM 3 wk-form3_1725483415.xml 3 1691
2 EX-24 skye_paxpoaedgar1.htm EX-24 5820
  Complete submission text file 0001516551-24-000083.txt   9285
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11250 EL CAMINO REAL, SUITE 100 ATTN: C/O SKYE BIOSCIENCE, INC. SAN DIEGO CA 92130
Business Address
Arora Puneet S. (Reporting) CIK: 0002035933 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42009 | Film No.: 241278380